Literature DB >> 15283740

Development of an antidepressant compliance questionnaire.

K Demyttenaere1, R Bruffaerts, A Albert, P Mesters, W Dewé, K Debruyckere, M Sangeleer.   

Abstract

OBJECTIVE: The development of the Antidepressant Compliance Questionnaire (ADCQ), assessing patients' attitudes and beliefs on depression and antidepressants.
METHOD: A 51-item questionnaire was applied to 85 psychiatric out-patients with a DSM-IV diagnosis of major depressive disorder (MDD). This data set was used to assess psychometric properties of the ADCQ. The questionnaire was also applied to 272 primary care out-patients with MDD.
RESULTS: A principal component analysis revealed four dimensions with good internal consistency and acceptable test-retest reliability: 'perceived doctor-patient relationship', 'preserved autonomy', 'positive beliefs on antidepressants' and 'partner agreement', resulting in a final questionnaire comprising 33-items. Responses were independent from depression severity and patient age. The response patterns of both psychiatric and primary care patients are provided and illustrate the many erroneous beliefs on antidepressants.
CONCLUSION: The ADCQ has good psychometric properties; further investigation should investigate whether this questionnaire is predictive of patient compliance.

Entities:  

Mesh:

Year:  2004        PMID: 15283740     DOI: 10.1111/j.1600-0447.2004.00350.x

Source DB:  PubMed          Journal:  Acta Psychiatr Scand        ISSN: 0001-690X            Impact factor:   6.392


  9 in total

1.  Satisfaction with medication is correlated with outcome but not persistence in patients treated with placebo, escitalopram, or serotonin-norepinephrine reuptake inhibitors: a post hoc analysis.

Authors:  Koen Demyttenaere; Elin Heldbo Reines; Sara Larsson Lönn; Malcolm Lader
Journal:  Prim Care Companion CNS Disord       Date:  2011

Review 2.  Fluoxetine versus other types of pharmacotherapy for depression.

Authors:  A Cipriani; P Brambilla; T Furukawa; J Geddes; M Gregis; M Hotopf; L Malvini; C Barbui
Journal:  Cochrane Database Syst Rev       Date:  2005-10-19

3.  Attitudes and beliefs of patients of first episode depression towards antidepressants and their adherence to treatment.

Authors:  Kaustav Chakraborty; Ajit Avasthi; Suresh Kumar; Sandeep Grover
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2008-11-13       Impact factor: 4.328

4.  A structural mean model to allow for noncompliance in a randomized trial comparing 2 active treatments.

Authors:  Krista Fischer; Els Goetghebeur; Bernard Vrijens; Ian R White
Journal:  Biostatistics       Date:  2010-08-30       Impact factor: 5.899

5.  Attitudes and beliefs among patients treated with mood stabilizers.

Authors:  Lars Vedel Kessing; Hanne Vibe Hansen; Per Bech
Journal:  Clin Pract Epidemiol Ment Health       Date:  2006-05-19

6.  Attitudes and beliefs of patients with chronic depression toward antidepressants and depression.

Authors:  Sabrina Anne Jacob; Ab Fatah Ab Rahman; Mohamed Azmi Ahmad Hassali
Journal:  Neuropsychiatr Dis Treat       Date:  2015-05-27       Impact factor: 2.570

7.  Attitudes toward psychotropic medications among patients with chronic psychiatric disorders and their family caregivers.

Authors:  Sandeep Grover; Subho Chakrabarti; Aarti Sharma; Shikha Tyagi
Journal:  J Neurosci Rural Pract       Date:  2014-10

8.  A Chinese and Western medication adherence scale in patients with Chronic Kidney Disease.

Authors:  Jiaowang Tan; Li Luo; Min Zhang; Huifen Chen; Dingjun Zhang; Chendi Dong; Bingqing Xia; Lizhe Fu; Fang Tang; Xusheng Liu; Qinxiang Tan; Yifan Wu
Journal:  Patient Prefer Adherence       Date:  2019-08-30       Impact factor: 2.711

9.  Identifying the Underlying Factors Associated With Patients' Attitudes Toward Antidepressants: Qualitative and Quantitative Analysis of Patient Drug Reviews.

Authors:  Maryam Zolnoori; Kin Wah Fung; Paul Fontelo; Hadi Kharrazi; Anthony Faiola; Yi Shuan Shirley Wu; Virginia Stoffel; Timothy Patrick
Journal:  JMIR Ment Health       Date:  2018-09-30
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.